|
|
||||||||
J Thorac Cardiovasc Surg 2007;134:865-870
© 2007 The American Association for Thoracic Surgery
General Thoracic Surgery |
a Medical Research Society, Vienna, Danube City; Department of Anesthesiology and Intensive Care, Sozialmedizinisches Zentrum Ost-Donauspital, Vienna, Austria
b Department of Pediatric Surgery, Sozialmedizinisches Zentrum Ost-Donauspital, Vienna, Austria
c Charité–University of Medicine Berlin, Institute for Clinical Epidemiology, Berlin, Germany
d Department of Special Anesthesiology and Pain Therapy, Vienna Medical University, General Hospital Vienna, Vienna, Austria.
Received for publication November 24, 2006; revisions received March 3, 2007; accepted for publication May 11, 2007. * Address for reprints: Thomas Weber, MD, DEEA, Medical Research Society, Vienna, Danube City, at the Sozialmedizinisches Zentrum Ost-Donauspital, Department of Anesthesiology and Intensive Care, Langobardenstrasse 122, A-1220 Vienna, Austria. (Email: thomas.weber{at}wienkav.at).
| Abstract |
|---|
|
|
|---|
Methods: We performed a prospective randomized trial with adolescents who had undergone minimally invasive pectus excavatum repair to compare postoperative pain using two different postoperative pain therapy settings: intravenous patient-controlled analgesia (n = 20) with morphine versus continuous thoracic epidural analgesia (n = 20) with 0.2% ropivacain containing 2 µg/mL fentanyl.
Results: Forty patients (32 male and 8 female patients) aged 10 to 28 years were studied. The thoracic epidural analgesia group showed lower pain scores (P < .0001) and required less additional pain medication in conjunction with greater well-being postoperatively (P < .0001) compared with patients receiving patient-controlled intravenous morphine. There was no significant difference regarding the incidence of sedation (P = .38), nausea (P = .10), and pruritus (P = .72) in both groups.
Conclusions: For adolescents undergoing minimally invasive pectus excavatum repair, thoracic epidural analgesia was superior to intravenous patient-controlled analgesia for postoperative analgesia, resulting in lower postoperative pain scores in conjunction with greater well-being.
| Introduction |
|---|
|
|
|---|
|
Pectus excavatum is the most common chest wall deformity in children, with an incidence of approximately 1 in 700 births. Since 1987, a minimally invasive approach first described by Nuss and coworkers1
has gained popularity.2,3
A convex retrosternal stainless-steel bar is placed and positioned between the midaxillary lines at the level of maximal pectus depth to correct the defect. Despite this minimally invasive technique, pectus excavatum operations are very painful procedures and postoperative pain management can be difficult.3
Adequate postoperative pain therapy is important far beyond the immediate postoperative period because sensitization to painful stimuli can cause chronic pain states or higher pain levels during subsequent surgical procedures. Nearly 80% of patients undergoing this procedure are children or adolescents.4
Although perioperative thoracic epidural analgesia (TEA) is recommended by many authors,5,6
others use intravenous patient-controlled analgesia (PCA)7,8
for postoperative analgesia after this surgical procedure. To date, no study is available that compares different types of pain management for pectus excavatum repair in a randomized prospective manner.
The aim of the current prospective randomized study was to compare postoperative pain relief, subjective well-being, and incidence of side effects in two different pain therapy settings: intravenous PCA versus TEA in adolescents undergoing minimally invasive pectus excavatum repair.
| Materials and Methods |
|---|
|
|
|---|
10 years) undergoing minimally invasive pectus excavatum repair at the Donauspital, Vienna, Austria, between October 2003 and April 2006 after obtaining approval from the institutional review board and written informed consent from each patient or his or her legal representative.
From previous data of this institution, we determined a minimal sample size of 17 patients per group to detect a difference between the 2 treatment groups of 2 visual analog scale (VAS) units with an estimated standard deviation of 2 by setting the ß value at 80% and the
value at .05 or less.
Participants
Of 52 patients eligible for the study, 12 refused participation. Forty patients (32 male and 8 female patients aged 10–28 years) were included.
Randomization into the 2 treatment groups (intravenous PCA [n = 20] and TEA [n = 20]) was done by using a computer-generated randomization list. Exclusion criteria were the refusal of a thoracic epidural catheter, pregnancy, bleeding history, and regular medication interfering with blood coagulation, except low-dose heparin. Dropout criteria in the TEA group were catheter dislocation, inflammation signs, or both at the catheter insertion site.
Anesthesia
Patients in the TEA group received a thoracic epidural catheter in the operating room immediately before surgical intervention after achievement of local anesthesia by using a median approach at Th6/7 or Th7/8, corresponding to the probable insertion site of the steel bar. Epidural space was identified by a loss-of-resistance technique with saline solution. The catheter was advanced 3 cm into the epidural space. A test dose of 2 mL of lidocaine 2% with epinephrine 1:200,000 was applied before using the epidural catheter to rule out intrathecal or intravasal malposition.
Induction of anesthesia was performed with 2.5 mg/kg propofol, 3 µg/kg fentanyl, and 0.6 mg/kg rocuronium for tracheal intubation. Anesthesia was maintained with 6 to 8 mg · kg–1 · h–1 propofol, normoventilation with air/oxygen mix at a fraction of inspired oxygen of 30%, and repetition doses of 1 to 2 µg/kg fentanyl and 0.1 mg/kg rocuronium at the discretion of the attending anesthesiologist. Fifteen minutes before the end of the operation, each patient received an intravenous bolus of 15 mg/kg acetaminophen.
After the induction of anesthesia, patients in the TEA group received a bolus of 0.2 mL/kg ropivacain 0.2% containing 2 µg/mL fentanyl, followed by a continuous rate of 0.2 mL/h of the same mixture administered epidurally. All patients were extubated in the operating room.
Postoperative Analgesia
Both groups received 1 mg/kg diclofenac administered intravenously every 8 hours until the fourth postoperative day.
Intravenous PCA group
Each patient could self-administer 0.02 mg/kg morphine as a bolus through a PCA pump (Cadd Prism; Smith Medical, Brunn am Gebirge, Austria); a lockout time of 6 minutes and a maximal rate of 6 boluses per hour was set. No additional continuous rate was applied.
TEA group
Each patient received ropivacain 0.2% containing 2 µg/mL fentanyl continuously at a rate of 0.2 mL · kg–1
· h–1 through the thoracic epidural catheter. Removal of the epidural catheter was performed on the fourth postoperative day (96 hours).
Rescue medication in case of break-through pain
At a VAS pain score of greater than 4, patients of both groups received an additional 15 mg/kg acetaminophen administered intravenously (maximum of 4 times a day). If, despite this, break-through pain was still experienced, additional opioids (1.5-mg piritramide boluses administered intravenously) were given in the PCA group, whereas patients in the TEA group received an additional epidural bolus of 0.1 mL/kg ropivacain 0.2% with 2 µg/mL fentanyl.
Supplemental oxygen was started at an oxygen saturation of less than 94% during spontaneous ventilation.
Surgical Procedure
A modification of the original method1
using a thoracoscope for the creation of the retrosternal tunnel was used.9
Except for in 1 patient assigned to the TEA group, all procedures were primary operations.
Data Collection
Pain as a primary end point was assessed by using an 11-point VAS (0 = no pain and 10 = maximal pain) at the end of anesthesia (0 hours), every 12 hours until the 96-hour postoperative time point, and at discharge. Additional pain medication requests were assessed by the nurse on the ward.
Subjective well-being was assessed by using a 101-point VAS (0 = no well-being and 100 = perfect well-being) on the day of the operation, the first and fifth postoperative days, at discharge, and 3 months after the operation.
Side Effects
Sedation was assessed on a numeric rating scale between 0 and 2 (0 = no sedation and 2 = deep sedation by a nurse on the ward). Nausea (presence or absence of) and pruritus were assessed by a nurse interviewing the patient. Time points were the end of anesthesia (0 hours), every 12 hours until the 96-hour postoperative time point, and discharge. Additional pain medication requests were assessed according to the same schedule. Local inflammation signs at the site of venipuncture and the epidural catheter were assessed daily by a nurse on the ward. The presence or absence of supplemental oxygen was recorded daily.
At discharge, both 3 and 6 months postoperatively, patients were interviewed as to whether they would choose the same form of anesthesia and perioperative pain management again and whether they experienced any limitations or pain caused by the operation.
Statistical Analysis
Statistical analysis was performed with SPSS 12.0.1 (SPSS, Inc, Chicago, Ill) and SAS 9.1 (SAS Institute, Inc, Cary, NC) software. For group comparison of categoric data, the Fisher exact test was used. Nonparametric multivariable analysis of variance for longitudinal data in a 2-factorial design (first factor: TEA vs PCA; second factor: time) was applied for the VAS and well-being scores.10
Incidence of side effects and the need for additional pain medication was examined by means of logistic regression. The generalized estimating equation method was used to account for dependencies arising from multiple assessments of the same patient (SAS, procedure Genmod).
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Although neurological complications related to thoracic epidural catheterization are feared by anesthesiologists, a predicted risk of 0.07% of permanent neurological complications is estimated in adults.16
The available data for children and adolescents reporting the risk of neurological complications related to thoracic epidural catheterization are scarce. In a French survey involving more than 15,000 central blocks, mostly during general anesthesia, Giaufré and colleagues17
similarly report a low incidence of adverse events with only minor complications, but most of the blocks were caudal blocks. To minimize the risk of neurologic damage, we performed the placement of thoracic epidural catheters after achievement of local anesthesia in awake patients before surgical intervention.
Although our study was not designed to detect differences in pulmonary outcome, we observed less use of supplementary oxygen in the thoracic epidural group, despite a rather high threshold (oxygen saturation < 94%) for supplemental oxygen administration. This observation might be explained by a difference in the incidence of postoperative atelectasis. Reduced incidence rates of atelectasis during epidural analgesia compared with systemic opioids are reported in a meta-analysis.18
Experiences of pain during childhood might increase the pain response during subsequent procedures.19
Therefore the quality of postoperative pain control seems to be a key issue, especially in children. Cucchiaro and colleagues20
showed that after major operations, children even seem to accept a higher rate of nausea and vomiting for superior pain control. However, superior analgesia did not result in a higher incidence of side effects in our trial. We therefore conclude that thoracic epidural analgesia is superior to intravenous PCA in adolescents undergoing minimally invasive pectus excavatum repair.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. Nagaso, J. Miyamoto, K. Kokaji, R. Yozu, H. Jiang, H. Jin, and T. Tamaki Double-bar application decreases postoperative pain after the Nuss procedure J. Thorac. Cardiovasc. Surg., July 1, 2010; 140(1): 39 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Grosen, M. Pfeiffer-Jensen, and H. K. Pilegaard Postoperative consumption of opioid analgesics following correction of pectus excavatum is influenced by pectus severity: a single-centre study of 236 patients undergoing minimally invasive correction of pectus excavatum Eur J Cardiothorac Surg, April 1, 2010; 37(4): 833 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Zingg, A. McQuinn, D. DiValentino, A. J. Esterman, J. R. Bessell, S. K. Thompson, G. G. Jamieson, and D. I. Watson Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer Ann. Thorac. Surg., March 1, 2009; 87(3): 911 - 919. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |